Home
R StocksTrader Stocks Live Prices
Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc.

Available to platforms

Lion Biotechnologies Inc. operates in the field of developing and commercializing new autologous cell therapy (ACT) for the treatment of various types of cancer. The company also plans to initiate clinical trials of its autologous cell therapy product using TIL as a second-line therapy for stage IV metastatic melanoma.

Iovance Biotherapeutics Inc. - IOVA stocks live chart

Analyze price movements of Iovance Biotherapeutics Inc. online with R StocksTrader’s advanced stock charts. There's no need to manually refresh the chart as quotes are updated automatically in real-time. View both the current and previous IOVA quotes – including the latest bid at 15.25 USD and ask at 15.4 USD – and get all the necessary information for adding Iovance Biotherapeutics Inc. to your investment portfolio.

With R StocksTrader, you can invest in Iovance Biotherapeutics Inc. and explore real stocks and CFDs on other prominent American and European companies. Stocks, Indices, Metals – over 12,000 assets are available for trading on our web terminal. Explore the dynamic price movements of popular assets, like Iovance Biotherapeutics Inc., and expand your trading opportunities by investing in new instruments in 2025.

Risk Warning: Past performance of IOVA does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for Iovance Biotherapeutics Inc. (IOVA).

You can trade Iovance Biotherapeutics Inc. (IOVA) on the R StocksTrader platform.

You can trade online Iovance Biotherapeutics Inc. (IOVA) on Prime, ECN, Pro, or R StocksTrader accounts.

All financial charts